175 related articles for article (PubMed ID: 23163113)
1. Plasma malondialdehyde levels and risk factors for the development of chronic complications in type 2 diabetic patients on insulin therapy.
Kaefer M; De Carvalho JA; Piva SJ; da Silva DB; Becker AM; Sangoi MB; Almeida TC; Hermes CL; Coelho AC; Tonello R; Moreira AP; Garcia SC; Moretto MB; Moresco RN
Clin Lab; 2012; 58(9-10):973-8. PubMed ID: 23163113
[TBL] [Abstract][Full Text] [Related]
2. The relationship between oxidative stress and the levels of serum circulating adhesion molecules in patients with hyperglycemia crises.
Shen XP; Li J; Zou S; Wu HJ; Zhang Y
J Diabetes Complications; 2012; 26(4):291-5. PubMed ID: 22658409
[TBL] [Abstract][Full Text] [Related]
3. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
[TBL] [Abstract][Full Text] [Related]
4. Increased lipid peroxidation in type 2 poorly controlled diabetic patients.
Altomare E; Vendemiale G; Chicco D; Procacci V; Cirelli F
Diabete Metab; 1992; 18(4):264-71. PubMed ID: 1459313
[TBL] [Abstract][Full Text] [Related]
5. Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity.
Kar P; Laight D; Rooprai HK; Shaw KM; Cummings M
Diabet Med; 2009 May; 26(5):526-31. PubMed ID: 19646193
[TBL] [Abstract][Full Text] [Related]
6. Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria.
Ozdemir G; Ozden M; Maral H; Kuskay S; Cetinalp P; Tarkun I
Ann Clin Biochem; 2005 Mar; 42(Pt 2):99-104. PubMed ID: 15829117
[TBL] [Abstract][Full Text] [Related]
7. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
Habib SS; Aslam M; Naveed AK; Razi MS
Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
[TBL] [Abstract][Full Text] [Related]
8. Reduced serum homocysteine levels in type 2 diabetes.
Mazza A; Bossone E; Mazza F; Distante A
Nutr Metab Cardiovasc Dis; 2005 Apr; 15(2):118-24. PubMed ID: 15871860
[TBL] [Abstract][Full Text] [Related]
9. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.
Likidlilid A; Patchanans N; Peerapatdit T; Sriratanasathavorn C
J Med Assoc Thai; 2010 Jun; 93(6):682-93. PubMed ID: 20572373
[TBL] [Abstract][Full Text] [Related]
10. Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients.
Peerapatdit T; Patchanans N; Likidlilid A; Poldee S; Sriratanasathavorn C
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S147-55. PubMed ID: 17718256
[TBL] [Abstract][Full Text] [Related]
11. Study of changes in antioxidant enzymes status in diabetic post menopausal group of women suffering from cardiovascular complications.
Kumawat M; Sharma TK; Singh N; Ghalaut VS; Vardey SK; Sinha M; Kaushik GG
Clin Lab; 2012; 58(3-4):203-7. PubMed ID: 22582492
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant status and lipid peroxidation end products in patients of type 1 diabetes mellitus.
Peerapatdit T; Likidlilid A; Patchanans N; Somkasetrin A
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S141-6. PubMed ID: 17718255
[TBL] [Abstract][Full Text] [Related]
13. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
Savage S; Estacio RO; Jeffers B; Schrier RW
Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress status in patients with diabetes mellitus: relationship to diet.
Dierckx N; Horvath G; van Gils C; Vertommen J; van de Vliet J; De Leeuw I; Manuel-y-Keenoy B
Eur J Clin Nutr; 2003 Aug; 57(8):999-1008. PubMed ID: 12879095
[TBL] [Abstract][Full Text] [Related]
15. Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade.
Agarwal R
Am J Physiol Renal Physiol; 2003 Apr; 284(4):F863-9. PubMed ID: 12505865
[TBL] [Abstract][Full Text] [Related]
16. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
[TBL] [Abstract][Full Text] [Related]
17. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.
Schaumberg DA; Glynn RJ; Jenkins AJ; Lyons TJ; Rifai N; Manson JE; Ridker PM; Nathan DM
Circulation; 2005 May; 111(19):2446-53. PubMed ID: 15867184
[TBL] [Abstract][Full Text] [Related]
18. Association of biomarkers of inflammation and oxidative stress with the risk of chronic kidney disease in Type 2 diabetes mellitus in North Indian population.
Gupta S; Gambhir JK; Kalra O; Gautam A; Shukla K; Mehndiratta M; Agarwal S; Shukla R
J Diabetes Complications; 2013; 27(6):548-52. PubMed ID: 24012111
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
Goldberg RB; Fonseca VA; Truitt KE; Jones MR
Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
[TBL] [Abstract][Full Text] [Related]
20. Experimental diabetic nephropathy can be prevented by propolis: Effect on metabolic disturbances and renal oxidative parameters.
Abo-Salem OM; El-Edel RH; Harisa GE; El-Halawany N; Ghonaim MM
Pak J Pharm Sci; 2009 Apr; 22(2):205-10. PubMed ID: 19339234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
